AI summary · may contain errors
Intismeran plus pembrolizumab sustained improved recurrence-free survival in resected stage IIIB–IV cutaneous melanoma, with HR 0.510 at 5 years versus pembrolizumab alone.
- 3 cited this week
Moving in Journal of Clinical Oncology.
Rebuilt
AI summary · may contain errors
Intismeran plus pembrolizumab sustained improved recurrence-free survival in resected stage IIIB–IV cutaneous melanoma, with HR 0.510 at 5 years versus pembrolizumab alone.
Newest first · last 60 days
AI summary · may contain errors
Occupational solar UVR exposure shows some non-monotonic positive association with incident ocular melanoma in the Norwegian Nor-Work cohort, with IRRs up to 1.80.
AI summary · may contain errors
Acral melanoma on palms, soles, and the nail apparatus shows low mutational burden but extensive structural genomic alterations, including CCND1 and TERT amplifications within clustered copy-number “hailstorms”/tyfonas.
AI summary · may contain errors
Lipid-associated TAMs (LA-TAMs) define a macrophage-centered immune neighborhood in melanoma that predicts poor ICI response and survival, linked to immune-excluded architecture.
AI summary · may contain errors
Patients in dermatology studies (20 included) show conditional support for AI, but consistently prefer dermatologist-supervised AI over autonomous AI, especially for high-stakes diagnosis.
AI summary · may contain errors
Disease-free survival and distant metastasis-free survival are strong surrogate endpoints for disease-specific survival in resected melanoma, with R2 up to 0.95 at 24–36 months.
AI summary · may contain errors
Five-year survival rates with neoadjuvant immune checkpoint inhibitors reach up to 87.5% in melanoma patients, especially among those achieving major pathological response.
AI summary · may contain errors
A deep learning model using routine whole-slide histopathology from early-stage melanoma predicts distant metastatic risk with added prognostic value beyond AJCC stage, achieving a best-fold balanced accuracy of 0.88.
AI summary · may contain errors
MGP-high cancer-associated fibroblasts suppress melanoma progression by reducing MDSC recruitment and survival, linked to TNFR2-cFLIP signaling inhibition and caspase-8 activation.
AI summary · may contain errors
Immune checkpoint gene phenotypes in cutaneous melanoma stratify overall survival, with ICG-high linked to longer survival versus ICG-low (HR 0.34, 95% CI 0.22–0.51).
AI summary · may contain errors
In the Sax Institute’s 45 and Up Study cohort in New South Wales, Australia, 6 melanoma risk models showed 10-year discrimination with AUCs from 0.58 to 0.70.
AI summary · may contain errors
Nivolumab plus axitinib in untreated advanced mucosal melanoma achieved a 45% objective response rate (RECIST v1.1) in 20 evaluable Western patients.
AI summary · may contain errors
Circulating thymidine kinase activity predicts survival in SECOMBIT trial patients with BRAF V600-mutated metastatic melanoma, with TKa-low showing 70.7% vs 36.9% overall survival.
AI summary · may contain errors
Expert histopathologic evaluation plus molecular testing resolved 966 of 994 (97.2%) ambiguous primary cutaneous melanocytic tumors, with long-term outcomes supporting clinical validity.
Journals this month
Topics moving, week to 17 Nov 2026
By field